Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Discovery Grants Program - Individual

McMaster University

$80,000.00

Xenobiotic and microbe stress promote muscle dysfunction

FY 2024-25

Summary
Metabolism fuels life by extracting useable energy from nutrients allowing the synthesis and maintenance of cellular constituents. Pathogen detection and removal requires a repertoire of sensors and chemical signals that are built and constantly modified using energy consuming processes. These processes are intricately linked in homeostatic responses required for tissue maintenance and repair, but the complexity of integrating immune and metabolic responses dictates the need for addressing fundamental basic science aspects of immunometabolism rather than considering each field alone. Objective 1 aims to understand how xenobiotics engage immune components that promote muscle dysfunction. We propose to build on our discoveries showing that all statins activate an immune response involving the Nod-like Nucleotide-Binding Oligomerization Domain, Leucine Rich Repeat And Pyrin Domain Containing 3 (NLRP3) inflammasome. We will test how NLRP3 acts as a metabolic danger sensor in response to fundamental shifts in muscle cell metabolism induced by statin-mediated lowering protein prenylation, independent of cholesterol. This is important because it may allow for targeting the side-effects of statins without compromising the cholesterol-lowering effects of this widely used drug class. This is applicable to any xenobiotic that targets the mevalonate pathway. We will also investigate how xenobiotics disrupt the Hippo pathway and Yes-associated protein (YAP) and transcriptional co-activator with PDZ-binding motif (TAZ) in muscle cell metabolism. Our exciting preliminary data and international collaboration positions Hippo signalling as a mediator of muscle defects caused by statin-induced lowering of prenylation and NLRP3-driven responses in a muscle cell autonomous manner. This would be the first implication of YAP/TAZ and NLRP3 connection in muscle dysfunction, where we will use newly developed human micro-muscle cultures. Objective 2 aims to understand how commensal bacteria influence endocrine control of muscle mass across the life-course, particularly focussing on muscle functional decline in ageing (i.e. sarcopenia). We have found that germ-free mice have worse sarcopenia. We have identified potential immune receptors that relay bacterial sensing to sarcopenia. Bacterial cell wall sensing by Nod1 is a key immune response that protects mice against sarcopenia. We propose to define how ageing alters sensing of commensal bacteria, which lower growth signals (GH and IGF-1) during sarcopenia. The long-term plan for this research program is to characterize how bacteria and xenobiotics engage specific aspects of host immunity to alter endocrine control of metabolism and muscle homeostasis. This foundational information is required in order to promote evidence-based development of microbiome strategies such as prebiotics, probiotics, and postbiotics and to prevent drug-induced myopathy with next generation drugs that avoid xenobiotic stress responses.
Program
Discovery Grants Program - Individual
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
RGPIN-2020-05707
Name nom
Schertzer, Jonathan
Department département
Biochemistry
Organization id
27
Institution établissement
McMaster University
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2024
Competition year année de concours
2020
Award amount
80000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1502
Committee name en
Biological Systems and Functions
Committee name fr
Systèmes et fonctions biologiques
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
5408
Research subject group en
Biochemistry
Research subject group fr
Biochimie
Research subject en
Metabolism
Research subject fr
Métabolisme
Field of research list names en
Not available
Field of research list names fr
Non disponible
Socioeconomic objective list names en
Not available
Socioeconomic objective list names fr
Non disponible
Application title
Xenobiotic and microbe stress promote muscle dysfunction
Keywords
immunometabolism; endocrinology; metabolism; immunity; inflammation; microbiome; growth factor; muscle; myopathy; cell stress
Application summary
Metabolism fuels life by extracting useable energy from nutrients allowing the synthesis and maintenance of cellular constituents. Pathogen detection and removal requires a repertoire of sensors and chemical signals that are built and constantly modified using energy consuming processes. These processes are intricately linked in homeostatic responses required for tissue maintenance and repair, but the complexity of integrating immune and metabolic responses dictates the need for addressing fundamental basic science aspects of immunometabolism rather than considering each field alone. Objective 1 aims to understand how xenobiotics engage immune components that promote muscle dysfunction. We propose to build on our discoveries showing that all statins activate an immune response involving the Nod-like Nucleotide-Binding Oligomerization Domain, Leucine Rich Repeat And Pyrin Domain Containing 3 (NLRP3) inflammasome. We will test how NLRP3 acts as a metabolic danger sensor in response to fundamental shifts in muscle cell metabolism induced by statin-mediated lowering protein prenylation, independent of cholesterol. This is important because it may allow for targeting the side-effects of statins without compromising the cholesterol-lowering effects of this widely used drug class. This is applicable to any xenobiotic that targets the mevalonate pathway. We will also investigate how xenobiotics disrupt the Hippo pathway and Yes-associated protein (YAP) and transcriptional co-activator with PDZ-binding motif (TAZ) in muscle cell metabolism. Our exciting preliminary data and international collaboration positions Hippo signalling as a mediator of muscle defects caused by statin-induced lowering of prenylation and NLRP3-driven responses in a muscle cell autonomous manner. This would be the first implication of YAP/TAZ and NLRP3 connection in muscle dysfunction, where we will use newly developed human micro-muscle cultures. Objective 2 aims to understand how commensal bacteria influence endocrine control of muscle mass across the life-course, particularly focussing on muscle functional decline in ageing (i.e. sarcopenia). We have found that germ-free mice have worse sarcopenia. We have identified potential immune receptors that relay bacterial sensing to sarcopenia. Bacterial cell wall sensing by Nod1 is a key immune response that protects mice against sarcopenia. We propose to define how ageing alters sensing of commensal bacteria, which lower growth signals (GH and IGF-1) during sarcopenia. The long-term plan for this research program is to characterize how bacteria and xenobiotics engage specific aspects of host immunity to alter endocrine control of metabolism and muscle homeostasis. This foundational information is required in order to promote evidence-based development of microbiome strategies such as prebiotics, probiotics, and postbiotics and to prevent drug-induced myopathy with next generation drugs that avoid xenobiotic stress responses.
McMaster University - $80,000 Grant (2024-25) | Canada Spends